Chee Fang Sum

6.6k total citations
179 papers, 4.6k citations indexed

About

Chee Fang Sum is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Chee Fang Sum has authored 179 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Endocrinology, Diabetes and Metabolism, 46 papers in Cardiology and Cardiovascular Medicine and 36 papers in Physiology. Recurrent topics in Chee Fang Sum's work include Diabetes, Cardiovascular Risks, and Lipoproteins (31 papers), Chronic Kidney Disease and Diabetes (29 papers) and Diabetes Treatment and Management (27 papers). Chee Fang Sum is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (31 papers), Chronic Kidney Disease and Diabetes (29 papers) and Diabetes Treatment and Management (27 papers). Chee Fang Sum collaborates with scholars based in Singapore, United States and Australia. Chee Fang Sum's co-authors include Tavintharan Subramaniam, Su Chi Lim, Jianjun Liu, Kandiah Jeyaseelan, Michael Wong, Dwi Setyowati Karolina, Arunmozhiarasi Armugam, Sylvia Liu, Serena Low and Sharon Li Ting Pek and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Chee Fang Sum

171 papers receiving 4.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chee Fang Sum Singapore 32 1.5k 1.4k 1.1k 750 710 179 4.6k
Christoph Meier Switzerland 45 1.3k 0.9× 575 0.4× 765 0.7× 665 0.9× 412 0.6× 94 5.3k
Kei Kamide Japan 41 1.2k 0.8× 863 0.6× 928 0.8× 523 0.7× 495 0.7× 239 5.7k
Fadi J. Charchar Australia 34 1.5k 1.0× 977 0.7× 953 0.9× 518 0.7× 612 0.9× 117 6.2k
Massimo Porta Italy 42 1.3k 0.8× 583 0.4× 2.1k 1.9× 897 1.2× 356 0.5× 184 7.0k
Masayuki Yokode Japan 41 1.6k 1.1× 734 0.5× 734 0.7× 832 1.1× 843 1.2× 141 5.8k
Carlo Sabbà Italy 46 1.5k 1.0× 846 0.6× 693 0.6× 1.3k 1.7× 490 0.7× 211 6.7k
Shyi‐Jang Shin Taiwan 36 968 0.6× 870 0.6× 1.3k 1.1× 1.7k 2.2× 217 0.3× 159 4.8k
Stephen M. Twigg Australia 48 1.9k 1.3× 1.0k 0.8× 2.7k 2.4× 1.2k 1.6× 541 0.8× 226 7.3k
Jerzy Chudek Poland 34 972 0.6× 1.0k 0.8× 463 0.4× 1.1k 1.5× 232 0.3× 410 5.4k
Manouchehr Nakhjavani Iran 33 913 0.6× 892 0.7× 1.7k 1.5× 1.1k 1.4× 153 0.2× 232 4.5k

Countries citing papers authored by Chee Fang Sum

Since Specialization
Citations

This map shows the geographic impact of Chee Fang Sum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chee Fang Sum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chee Fang Sum more than expected).

Fields of papers citing papers by Chee Fang Sum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chee Fang Sum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chee Fang Sum. The network helps show where Chee Fang Sum may publish in the future.

Co-authorship network of co-authors of Chee Fang Sum

This figure shows the co-authorship network connecting the top 25 collaborators of Chee Fang Sum. A scholar is included among the top collaborators of Chee Fang Sum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chee Fang Sum. Chee Fang Sum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Low, Serena, Tze Pin Ng, Angela Moh, et al.. (2024). Reduced skeletal muscle mass to visceral fat area ratio is independently associated with reduced cognitive function in type 2 diabetes mellitus. Journal of Diabetes and its Complications. 38(2). 108672–108672. 4 indexed citations
2.
Gurung, Resham L, Sylvia Liu, Jianjun Liu, et al.. (2024). Association of plasma angiogenin with risk of major cardiovascular events in type 2 diabetes. Cardiovascular Diabetology. 23(1). 70–70. 4 indexed citations
3.
Abdin, Edimansyah, P. V. Asharani, Fiona Devi, et al.. (2024). Prevalence of diabetes mellitus-related complications and their impact on health-related quality of life in Singapore. Singapore Medical Journal.
4.
Gurung, Resham L, Sylvia Liu, Huili Zheng, et al.. (2024). Association of plasma ceramide with decline in kidney function in patients with type 2 diabetes. Journal of Lipid Research. 65(6). 100552–100552. 1 indexed citations
5.
Gurung, Resham L, Huili Zheng, Sylvia Liu, et al.. (2024). Plasma Proteomics of Diabetic Kidney Disease Among Asians With Younger-Onset Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 110(2). e239–e248. 8 indexed citations
6.
Asharani, P. V., Fiona Devi, Kumarasan Roystonn, et al.. (2023). Benefits of leisure-related physical activity and association between sedentary time and risk for hypertension and type 2 diabetes. Annals of the Academy of Medicine Singapore. 52(4). 172–181.
7.
Low, Serena, Allen Yan Lun Liu, Yi Ming Shao, et al.. (2023). Association between self-care and chronic kidney disease in patients with type 2 diabetes mellitus. Annals of the Academy of Medicine Singapore. 52(1). 52–54. 1 indexed citations
8.
Low, Serena, Sharon Li Ting Pek, Angela Moh, et al.. (2023). Association between lower phase angle and chronic kidney disease progression in type 2 diabetes patients. Annals of the Academy of Medicine Singapore. 52(3). 125–134. 2 indexed citations
9.
Liu, Jianjun, Jianhong Ching, Sylvia Liu, et al.. (2023). Plasma Tryptophan-Kynurenine Pathway Metabolites and Risk for Progression to End-Stage Kidney Disease in Patients With Type 2 Diabetes. Diabetes Care. 46(12). 2223–2231. 21 indexed citations
10.
Low, Serena, Tze Pin Ng, Angela Moh, et al.. (2022). Decline in skeletal muscle mass is associated with cognitive decline in type 2 diabetes mellitus. Journal of Diabetes and its Complications. 36(9). 108258–108258. 6 indexed citations
11.
Roystonn, Kumarasan, Jue Hua Lau, P. V. Asharani, et al.. (2022). Recognition of diabetes and sociodemographic predictors: results of a cross-sectional nationwide population-based survey in Singapore. BMJ Open. 12(3). e050425–e050425. 5 indexed citations
12.
Ang, Su Fen, Ester Yeoh, Wann Jia Loh, et al.. (2022). MODY5 Hepatocyte Nuclear Factor 1ß (HNF1ß)-Associated Nephropathy: experience from a regional monogenic diabetes referral centre in Singapore. Journal of Investigative Medicine High Impact Case Reports. 10. 1605913370–1605913370. 3 indexed citations
13.
Asharani, P. V., Jue Hua Lau, Kumarasan Roystonn, et al.. (2021). Readiness and Acceptance of eHealth Services for Diabetes Care in the General Population: Cross-sectional Study. Journal of Medical Internet Research. 23(9). e26881–e26881. 18 indexed citations
14.
Asharani, P. V., Jue Hua Lau, Kumarasan Roystonn, et al.. (2021). Health Literacy and Diabetes Knowledge: A Nationwide Survey in a Multi-Ethnic Population. International Journal of Environmental Research and Public Health. 18(17). 9316–9316. 30 indexed citations
15.
Subramaniam, Mythily, P. V. Asharani, Fiona Devi, et al.. (2021). The Prevalence and Correlates of Disability in Singapore: Results from a Nationwide Cross-Sectional Survey. International Journal of Environmental Research and Public Health. 18(24). 13090–13090. 4 indexed citations
16.
Low, Serena, Tze Pin Ng, Chin Leong Lim, et al.. (2020). Higher ratio of extracellular water to total body water was associated with reduced cognitive function in type 2 diabetes. Journal of Diabetes. 13(3). 222–231. 22 indexed citations
18.
Liu, Jianjun, et al.. (2013). Acetyl-keto-β-boswellic acid induces lipolysis in mature adipocytes. Biochemical and Biophysical Research Communications. 431(2). 192–196. 20 indexed citations
19.
Karolina, Dwi Setyowati, Arunmozhiarasi Armugam, Tavintharan Subramaniam, et al.. (2011). Correction: MicroRNA 144 Impairs Insulin Signaling by Inhibiting the Expression of Insulin Receptor Substrate 1 in Type 2 Diabetes Mellitus. PLoS ONE. 6(9). 72 indexed citations
20.
Sum, Chee Fang, et al.. (1996). Management of hyperlipidaemia. Drug and Therapeutics Bulletin. 34(12). 89–93. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026